CClinicalTrials.gg
RecruitingNCT07732803Updated Jul 29, 2026

Outcomes for Robotics in Orthopaedic Trauma

An interventional study of Robotic Assistance: The robotic system (R-Universal® Intelligent Robotic Surgical Systems, Beijing Rossum Robot Technology Co., Ltd.) in Orthopaedic Trauma, sponsored by Prince of Wales Hospital, Shatin, Hong Kong. Recruiting at 1 site in China. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-07-29.

Sponsored by Prince of Wales Hospital, Shatin, Hong Kong · Not applicable, Interventional, and Supportive care

From the registry’s dates

  • Started Jun 2026; still recruiting 3 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
200
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Our project aims to integrate whether robotic assistance of reduction and fixation in orthopaedic trauma surgery can enhance accuracy and surgical outcomes. The current study aims to shorten the recovery time and reduce post-operative complications by minimally invasive surgery with robotics.

Read the detailed description
  1. To assess whether robotic assistance can improve surgical outcomes compared with control group.
  2. To assess whether robotic assistance can improve fracture reduction compared with control group.
  3. To assess whether robotic assistance can reduce complication rate compared with control group.
02

Conditions studied

  • Orthopaedic Trauma

Keywords

  • Orthopaedic Trauma
  • Robotics
03

In context

Lead sponsor

Prince of Wales Hospital, Shatin, Hong Kong is the lead sponsor of 27 studies on the registry; 15 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Males or females aged 18 years or older
  • With orthopaedic trauma and fracture
  • Willing to participate in the study

Exclusion criteria

Exclusion Criteria:

  • Cognitive problems e.g., severe dementia (unable to agree for consent)
  • Unable to agree for consent
  • Surgeons decide that surgery is not indicated for the patients
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
200 participants (estimated)

Study arms

  • No intervention
    Control group

    Surgery will be performed using conventional practice without robotic assistance

  • Experimental
    Robot-assisted group

    The robotic system (R-Universal® Intelligent Robotic Surgical Systems, Beijing Rossum Robot Technology Co., Ltd.) will be moved to the site of injury and held to the pins placed onto bone as the preoperative plan. The reduction process will be completed under the supervision of 3D real-time navigation. The fracture is then fixated. The robotic arm will perform precise movements during surgery for reduction to try to reduce the chance of malalignment. Moreover, these robots can allow minimally invasive surgeries.

    Device: Robotic Assistance: The robotic system (R-Universal® Intelligent Robotic Surgical Systems, Beijing Rossum Robot Technology Co., Ltd.)

Interventions

  • DeviceRobotic Assistance: The robotic system (R-Universal® Intelligent Robotic Surgical Systems, Beijing Rossum Robot Technology Co., Ltd.)

    The robotic system (R-Universal® Intelligent Robotic Surgical Systems, Beijing Rossum Robot Technology Co., Ltd.) will be moved to the site of injury and held to the pins placed onto bone as the preoperative plan. The reduction process will be completed under the supervision of 3D real-time navigation. The fracture is then fixated. The robotic arm will perform precise movements during surgery for reduction to try to reduce the chance of malalignment. Moreover, these robots can allow minimally invasive surgeries.

06

What researchers measure

Primary outcomes

  1. Operation Time

    Operation time will be documented from the Clinical Management System (CMS).

    Time frame: Baseline

  2. Blood Loss

    Blood loss will be documented from the Clinical Management System (CMS).

    Time frame: Baseline

  3. Length of Hospital Stay

    Length of hospital stay will be documented from the Clinical Management System (CMS).

    Time frame: Baseline

  4. Plain Radiographs

    Plain radiographs will be taken at the corresponding sites of injuries post operation. The reduction quality will be assessed based on Matta criteria

    Time frame: From baseline to 52-weeks post-operation

  5. Computed Tomography (CT)

    CT scan will be taken at the corresponding sites of injuries pre- and post operation.

    Time frame: From baseline to 12-weeks post-operation

Secondary outcomes

  1. Quality of life Short Form-36 (SF-36)

    is a widely accepted, well-validated functional status questionnaire to measure health-related quality of life in eight domains, including physical functioning, health perception, etc. Higher scores indicate better function

    Time frame: From baseline to 52-weeks post-operation

  2. Verbal Descriptor Scale

    to assess different levels of pain intensity, which has good reliability and validity in elderly patients

    Time frame: From baseline to 52-weeks post-operation

  3. Quadriceps muscle strength

    measured on affected limb with isometric dynamometer (Baseline, Genova, Italy). Subject will sit on a chair with both feet above ground, while raising the affected leg 45° forwards. The dynamometer is placed above the ankle and the subject will push the leg forward with maximum force. Measurements will be repeated three times and maximum value (kg) will be used for evaluation.

    Time frame: From baseline to 52-weeks post-operation

  4. Times Up and Go (TUG) test

    used to test basic mobility skills, which is a useful predictor of risk of falls. The subject will stand from a chair, walk 3 meters and travel back and sit back on the chair. The time (second) is recorded.

    Time frame: From baseline to 52-weeks post-operation

  5. Handgrip strength

    Grip strength measurement using spring-type hand dynamometer. Maximum reading (kg) of 3 trials using dominant hand in a maximum-effort isometric contraction is taken.

    Time frame: From baseline to 52-weeks post-operation

  6. 5-time chair stand test

    The time to rise from a chair 5 times is recorded. The cut-off is taken at \>=12 seconds.

    Time frame: From baseline to 52-weeks post-operation

  7. Appendicular skeletal muscle mass (ASM)

    Determined with Dual-energy X-ray absorptiometry (Horizon®, DXA system, Hologic, USA) or bioimpedance analysis (BIA). Total ASM by DXA is evaluated by segmented measurement of muscle mass at four limbs by operator-defined cutlines at specific anatomical landmarks. ASM is adjusted to square of height to calculate appendicular skeletal muscle mass index (ASMI) (kg/m2).

    Time frame: From baseline to 52-weeks post-operation

  8. 6-metre walk

    Time taken to walk 6 metres without deceleration. Average result of 2 trials is recorded. Slow speed is defined as \<1.0m/s.

    Time frame: From baseline to 52-weeks post-operation

  9. Adverse event and serious adverse event

    Adverse events and serious adverse events are documented from the Clinical Management System (CMS) from Hospital Authority (public computerized system for all patients).

    Time frame: From 2-weeks post-operation to 52-weeks post-operation

  10. Balancing ability

    The Basic Balance Master System (NeuroCom International Inc, USA) is used to measure static and dynamic ability of subjects to maintain center of balance. Subjects will stand barefoot on force plate and control location of their center-of-gravity by weight-shifting to eight different target directions without falling or moving their feet. Measured parameters of limits of stability test includes reaction time(s).

    Time frame: From baseline to 52-weeks post-operation

  11. Balancing ability

    The Basic Balance Master System (NeuroCom International Inc, USA) is used to measure static and dynamic ability of subjects to maintain center of balance. Subjects will stand barefoot on force plate and control location of their center-of-gravity by weight-shifting to eight different target directions without falling or moving their feet. Measured parameters of limits of stability test includes directional control (%).

    Time frame: From baseline to 52-weeks post-operation

  12. Balancing ability

    The Basic Balance Master System (NeuroCom International Inc, USA) is used to measure static and dynamic ability of subjects to maintain center of balance. Subjects will stand barefoot on force plate and control location of their center-of-gravity by weight-shifting to eight different target directions without falling or moving their feet. Measured parameters of limits of stability test includes movement velocity (degrees/s).

    Time frame: From baseline to 52-weeks post-operation

  13. Balancing ability

    The Basic Balance Master System (NeuroCom International Inc, USA) is used to measure static and dynamic ability of subjects to maintain center of balance. Subjects will stand barefoot on force plate and control location of their center-of-gravity by weight-shifting to eight different target directions without falling or moving their feet. Measured parameters of limits of stability test includes endpoint excursion (%).

    Time frame: From baseline to 52-weeks post-operation

  14. Balancing ability

    The Basic Balance Master System (NeuroCom International Inc, USA) is used to measure static and dynamic ability of subjects to maintain center of balance. Subjects will stand barefoot on force plate and control location of their center-of-gravity by weight-shifting to eight different target directions without falling or moving their feet. Measured parameters of limits of stability test includes maximum excursion (%).

    Time frame: From baseline to 52-weeks post-operation

07

Study locations

1 of 1 sites recruiting
  • The Chinese University of Hong Kong
    Hong Kong, China
    • Ronald Man Yeung Wong · Contact · ronald.wong@cuhk.edu.hk · 852 3505 1654
    • Ronald Man Yeung Wong · Principal investigator
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 29, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07732803
Lead sponsor
Prince of Wales Hospital, Shatin, Hong Kong
Responsible party
Ronald Man Yeung WONG (Clinical Associate Professor, Prince of Wales Hospital, Shatin, Hong Kong) — Principal investigator
First posted
Jul 29, 2026
Start date
Jun 15, 2026
Primary completion
Feb 28, 2030 (estimated)
Completion
Mar 1, 2031 (estimated)
Last update
Jul 29, 2026

Study contacts

Ronald Man Yeung Wong
Contact
ronald.wong@cuhk.edu.hk
852 35051654

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion